about
Thymus cell antigen 1, thetaHyaluronidase 2Receptor for activated C kinase 1SH3 domain binding protein 5SH3 binding domain protein 5 likeProtein tyrosine kinase 6Gametogenetin binding protein 2Caveolin 1Inhibitor of Bruton tyrosine kinaseSRC kinase signaling inhibitor 1Protein tyrosine phosphatase non-receptor type 2Centrosomal protein 43Inhibitor of Bruton agammaglobulinemia tyrosine kinaseCaveolin 1, caveolae proteinMajor vault proteinPTK6 protein tyrosine kinase 6Centrosomal protein 43Receptor for activated C kinase 1Gametogenetin binding protein 2SH3 binding domain protein 5 likeSH3-domain binding protein 5 (BTK-associated)Hyaluronoglucosaminidase 2SRC kinase signaling inhibitor 1Alpha-2-HS-glycoproteinProtein tyrosine phosphatase, receptor type, CProtein tyrosine phosphatase, non-receptor type 2Centrosomal protein 43SRC kinase signaling inhibitor 1Receptor for activated C kinase 1Thy-1 cell surface antigenSH3-domain binding protein 5Protein tyrosine phosphatase, non-receptor type 2Alpha-2-HS-glycoproteinSH3 binding domain protein 5 likeProtein tyrosine kinase 6Guanine nucleotide exchange factor rei-1 CELE_C03C10.4Guanine nucleotide exchange factor rei-2 CELE_K03E6.7Uncharacterized protein Dmel_CG8060Parcas Dmel_CG7761Kurtz Dmel_CG1487
P682
Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirusCrosstalk between Src and major vault protein in epidermal growth factor-dependent cell signallingp140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activityRegulated association of protein kinase B/Akt with breast tumor kinase
P921
Q14906181-D5A6415B-A810-41BF-B875-2D4F02D427F2Q21103082-6BED30A7-7F78-4338-B4EB-1ED185A1311FQ21104919-88729717-EDCF-4B17-BE39-52888B5E3CCBQ21111118-351D7A41-4900-484C-A355-58D8CA938D6BQ21111130-CCFC80A0-F9D4-4337-8D6D-2F5CAE1CC245Q21114361-60BC48F9-E610-48FC-877D-9E3D3C3E8D1CQ21114614-FF7F5173-199D-4A68-97DD-2CE4E6B732B9Q21115385-84EEB725-491C-4AFF-9A95-6D4676245526Q21115385-F16288BA-92D1-4D0A-94BF-118D8A54FC34Q21118428-D2238C61-9B71-455B-B747-F5B07F273E09Q21131173-8A5EF9C6-AF13-46BA-9ED6-F3D28BD04F14Q21171735-79208ACD-D767-4F1A-8F7B-3F08FF9834E5Q21245853-1E4CC79A-AF2C-4DC9-91FE-D7A7A5855680Q21495861-3D948A49-24AB-47E1-ACA8-D9A946B9D10DQ21497997-7929961E-2CD3-4230-AD44-3B7682E13CC0Q21497997-CBD78D5D-A75F-42F2-A581-6AD94A6ED019Q21980030-36FC8367-5D21-4875-AA6F-C1743EA01EB0Q21980116-96C433B1-3437-4D18-9396-13BC7944E432Q21981367-90C251B6-DBC0-435A-9DD2-7E345F623ED4Q21981598-1A8CB93D-E5AC-4CC2-B391-05F8001CDBE9Q21982086-7C3B021D-4126-44D5-BAA3-FA4E743A1435Q21982654-A0FBC3F6-F5BD-4C45-BC8C-55E8B2A1489CQ21982661-E8E20238-C562-460F-A489-D300A25C16BBQ21984507-4D201031-0318-4DAB-861F-A22F2EF9DC41Q21984746-B0BA6884-239F-43AB-BBBF-874D7807F41BQ21985333-57EFDC14-13C1-4EA5-96CF-69FC8F2C59DDQ21985631-FA292323-7049-4354-AFA2-77CB23DDCDCAQ21990494-333FA270-1214-4177-BDF1-C7D6D41EBBF1Q28556660-9DFED77E-E579-4039-91F5-21AEAC17A3BFQ28557447-34913322-CB03-45AF-9DFD-C677BDBAE625Q28558162-02242A24-F197-44C2-A1A0-48B89CC0907FQ28559057-C6276EEA-9A87-44EC-92B7-61C8DE4191AFQ28561353-CB8D431C-193A-4CB5-A378-1FD726451F58Q28562476-23321330-8C67-4F9A-B4E1-0768E850262CQ28562606-6CFC97C7-C07F-4AFF-BB71-F08A4B7A8D3FQ29520717-CDC5A1BA-37D6-4F9A-B992-7931558AC5AAQ29527285-D5F7C11D-F96A-4099-988A-A46B85CA97A0Q29793452-E2205CF2-5EDE-4BF3-8C71-C1C8A5F2D719Q29799505-4ADFC296-6C55-4D27-AE41-C59ED7ABAD4EQ29808767-87634D69-DD6D-4A82-945E-B8CB8A6477E4
P682
description
Any process that decreases the ...... tein tyrosine kinase activity.
@en
biologisch proces
@nl
name
negative regulation of protein tyrosine kinase activity
@en
type
label
negative regulation of protein tyrosine kinase activity
@en
prefLabel
negative regulation of protein tyrosine kinase activity
@en
P279
P279
P2888
P686
GO:0061099